罗格列酮对血管紧张素Ⅱ诱导血管平滑肌细胞增殖的影响
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

国家自然科学基金(34840042)


Effects of Rosiglitazone on Proliferation of Vascular Smooth Muscle Cells Induced by Angiotensin Ⅱ
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的探讨罗格列酮对血管紧张素Ⅱ诱导血管平滑肌细胞增殖的影响及可能的机制。方法原代培养大鼠血管平滑肌细胞,取第4~8代细胞进行实验。用终浓度为1μmol/L血管紧张素Ⅱ诱导6 h,随机分成对照组(含10%FBS的DMEM培养基)、1μmol/L血管紧张素Ⅱ组、不同浓度罗格列酮(20、30、40及50μmol/L)干预组,30μmol/L罗格列酮干预不同时间组(6、12、18及24 h)。分别采用MTT和流式细胞术观察血管平滑肌细胞增殖和增殖周期的变化;逆转录聚合酶链反应和免疫印迹法测定不同干预条件下血管平滑肌细胞血管紧张素Ⅱ2型受体mRNA和蛋白的表达水平。结果血管紧张素Ⅱ组吸光值明显高于对照组(P><0.01),20、30、40及50μmol/L罗格列酮干预12 h及30μmol/L罗格列酮干预6、12、18及24 h后,吸光值明显降低(P><0.05或P><0.01);血管紧张素Ⅱ组增殖指数和S期细胞分数明显高于对照组(P><0.01)。随着罗格列酮干预浓度的增加或干预时间的延长,增殖指数、S期细胞分数及处于S期分数均明显下降(P><0.05或P><0.01)。与血管紧张素Ⅱ组相比,不同浓度(20、30及50μmol/L)罗格列酮干预12 h及同一浓度(30μmol/L)干预不同时间(6、12及24 h)显著升高血管紧张素Ⅱ2型受体mRNA和蛋白的表达(P><0.05或P><0.01)。结论罗格列酮至少部分通过上调血管紧张素Ⅱ2型受体表达,阻止血管平滑肌细胞从G0/G1期向S期、G2/M期转化,从而抑制血管紧张素Ⅱ诱导血管平滑肌细胞的增殖、迁移,发挥血管保护作用。

    Abstract:

    Aim To investigate the effects of rosiglitazone on the proliferation of vascular smooth muscle cells induced by angiotensinⅡ(AngⅡ) and possible mechanism. Methods Vascular smooth muscle cells(VSMC) were isolated from aortic media of four-week-old male Sprague-Dawley rats by enzymatic digestion and cultured in monolayer.VSMC in passage 4~8 in log phase were used in following experiments.VSMC were treated by 1 μmol/L AngⅡ for 6 h and randomly divided into the groups as follows: control group(10% FBS in DMEM),Ang Ⅱ group(1 μmol/L AngⅡ),groups respectively treated with different concentration of rosiglitazone(20,30,40 and 50 μmol/L) for 12 h and groups respectively treated with 30 μmol/L rosiglitazone for 6,12,18 and 24 h.The VSMC growth,change of proliferation cycle and mRNA and protein expression of AngⅡ type 2 receptor(AT2R) in all groups were detected by using MTT colorimetric assay,FCM,RT-PCR and Western blotting. Results The mean absorbance(A value) in the VSMC treated by AngⅡ was significantly higher as compared with that of the control group(P><0.01).The A values were markedly reduced in the VSMC treated by different concentration of rosiglitazone for 12 h or 30 μmol/L rosiglitazone for 6,12,18 and 24 h(P><0.05 or P><0.01).The proliferation index(PI) and S-phase fraction(SPF) in the AngⅡ group were significantly higher than those of the control group(P><0.01).With the increase in rosiglitazone concentration and prolongation of treatment time,PI and SPF were greatly reduced(P><0.05 or P><0.01).Compared with the AngⅡ group,expression of AT2R mRNA and protein in the VSMC with the treatment of 20,30 and 50 μmol/L rosiglitazone for 12 h or of 30 μmol/L rosiglitazone for 6,12 and 24 h were both markedly increased(P><0.05 or P><0.01),reaching a maximum in 50 μmol/L rosiglitazone for 12 h or 30 μmol/L rosiglitazone for 24 h. Conclusions Rosiglitazone inhibited VSMC proliferation induced by AngⅡ at least partially through up-regulating expression of AT2R both at mRNA and protein levels in a concentration-dependent and time-dependent manner,in order to play vasculoprotective role.

    参考文献
    相似文献
    引证文献
引用本文

任利群,李荥娟,郭晓珍,盛祖龙,刘乃丰.罗格列酮对血管紧张素Ⅱ诱导血管平滑肌细胞增殖的影响[J].中国动脉硬化杂志,2010,18(9):682~686.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2010-07-15
  • 最后修改日期:2010-09-07
  • 录用日期:
  • 在线发布日期: